4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Zhenghui Gordon Jiang, Simon C. Robson, Zemin Yao. Lipoprotein metabolism in nonalcoholic fatty liver disease[J]. The Journal of Biomedical Research, 2013, 27(1): 1-13. DOI: 10.7555/JBR.27.20120077
Citation: Zhenghui Gordon Jiang, Simon C. Robson, Zemin Yao. Lipoprotein metabolism in nonalcoholic fatty liver disease[J]. The Journal of Biomedical Research, 2013, 27(1): 1-13. DOI: 10.7555/JBR.27.20120077

Lipoprotein metabolism in nonalcoholic fatty liver disease

  • Nonalcoholic fatty liver disease (NAFLD), an escalating health problem worldwide, covers a spectrum of pathologies characterized by fatty accumulation in hepatocytes in early stages, with potential progression to liver inflammation, fibrosis, and failure. A close, yet poorly understood link exists between NAFLD and dyslipidemia, a constellation of abnormalities in plasma lipoproteins including triglyceride-rich very low density lipoproteins. Apolipoproteins are a group of primarily liver-derived proteins found in serum lipoproteins; they not only play an extracellular role in lipid transport between vital organs through circulation, but also play an important intracellu-lar role in hepatic lipoprotein assembly and secretion. The liver functions as the central hub for lipoprotein metab-olism, as it dictates lipoprotein production and to a significant extent modulates lipoprotein clearance. Lipoprotein metabolism is an integral component of hepatocellular lipid homeostasis and is implicated in the pathogenesis, potential diagnosis, and treatment of NAFLD.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return